CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sysmed china Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sysmed china Co Ltd
11-2-3
No.17 Wensu Street, Hunnan New District
Phone: +86 2423970020p:+86 2423970020 Shenyang, LIA  China Fax: +86 2423970020f:+86 2423970020

Business Summary
SYSMED(CHINA) CO., LTD is principally engaged in the research and development (R&D), production and sale of oxygen therapy equipment and respiratory therapy equipment. The Company’s main products portfolio consists of oxygen and ventilators, including O-Cure series, O-intelligence series, Y series, DPAP series and others. The Company distributes its products within domestic market and overseas markets, including South America, the Middle East, Southeast Asia and others.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201512/31/2013Yes----

General Information
Outstanding Shares: 25,800,000 (As of 12/31/2014)
Fax Number: +86 2423970020


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023